RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells

Abstract Background Nasopharyngeal carcinoma (NPC) is a tumor deriving from nasopharyngeal epithelium. Peptidyl-arginine deiminase 4 (PAD4) is a vital mediator of histone citrullination and plays an essential role in regulating disease process. Radiotherapy is an essential method to treat NPC. In th...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Chen, Min Luo, Xiangping Wang, Ting Liang, Chaoyuan Huang, Changjie Huang, Lining Wei
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Cellular & Molecular Biology Letters
Subjects:
Online Access:https://doi.org/10.1186/s11658-021-00251-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559236823220224
author Hao Chen
Min Luo
Xiangping Wang
Ting Liang
Chaoyuan Huang
Changjie Huang
Lining Wei
author_facet Hao Chen
Min Luo
Xiangping Wang
Ting Liang
Chaoyuan Huang
Changjie Huang
Lining Wei
author_sort Hao Chen
collection DOAJ
description Abstract Background Nasopharyngeal carcinoma (NPC) is a tumor deriving from nasopharyngeal epithelium. Peptidyl-arginine deiminase 4 (PAD4) is a vital mediator of histone citrullination and plays an essential role in regulating disease process. Radiotherapy is an essential method to treat NPC. In this research, we explored the effect of PAD4 on NPC radiosensitivity. Methods We enrolled 50 NPC patients, established mice xenograft model, and purchased cell lines for this study. Statistical analysis and a series of experiments including RT-qPCR, clonogenic survival, EdU, Transwell, and wound healing assays were done. Results Our data manifested that PAD4 (mRNA and protein) presented a high expression in NPC tissues and cells. GSK484, an inhibitor of PAD4, could inhibit activity of PAD4 in NPC cell lines. PAD4 overexpression promoted the radioresistance, survival, migration, and invasion of NPC cells, whereas treatment of GSK484 exerted inhibitory effects on radioresistance and aggressive phenotype of NPC cells. Additionally, GSK484 could attenuate the effect of PAD4 of NPC cell progression. More importantly, we found that GSK484 significantly inhibited tumor size, tumor weight and tumor volume in mice following irradiation. Conclusions PAD4 inhibitor GSK484 attenuated the radioresistance and cellular progression in NPC.
format Article
id doaj-art-b5e858beb35148c591f6410643b13a81
institution Kabale University
issn 1425-8153
1689-1392
language English
publishDate 2021-03-01
publisher BMC
record_format Article
series Cellular & Molecular Biology Letters
spelling doaj-art-b5e858beb35148c591f6410643b13a812025-01-05T12:41:15ZengBMCCellular & Molecular Biology Letters1425-81531689-13922021-03-0126111210.1186/s11658-021-00251-2RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cellsHao Chen0Min Luo1Xiangping Wang2Ting Liang3Chaoyuan Huang4Changjie Huang5Lining Wei6Department of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Endoscopy, The Affiliated Tumor Hospital of Guangxi Medical UniversityDepartment of Oncology, The Second Nanning People’s HospitalAbstract Background Nasopharyngeal carcinoma (NPC) is a tumor deriving from nasopharyngeal epithelium. Peptidyl-arginine deiminase 4 (PAD4) is a vital mediator of histone citrullination and plays an essential role in regulating disease process. Radiotherapy is an essential method to treat NPC. In this research, we explored the effect of PAD4 on NPC radiosensitivity. Methods We enrolled 50 NPC patients, established mice xenograft model, and purchased cell lines for this study. Statistical analysis and a series of experiments including RT-qPCR, clonogenic survival, EdU, Transwell, and wound healing assays were done. Results Our data manifested that PAD4 (mRNA and protein) presented a high expression in NPC tissues and cells. GSK484, an inhibitor of PAD4, could inhibit activity of PAD4 in NPC cell lines. PAD4 overexpression promoted the radioresistance, survival, migration, and invasion of NPC cells, whereas treatment of GSK484 exerted inhibitory effects on radioresistance and aggressive phenotype of NPC cells. Additionally, GSK484 could attenuate the effect of PAD4 of NPC cell progression. More importantly, we found that GSK484 significantly inhibited tumor size, tumor weight and tumor volume in mice following irradiation. Conclusions PAD4 inhibitor GSK484 attenuated the radioresistance and cellular progression in NPC.https://doi.org/10.1186/s11658-021-00251-2PAD4GSK484RadiosensitivityNasopharyngeal carcinoma
spellingShingle Hao Chen
Min Luo
Xiangping Wang
Ting Liang
Chaoyuan Huang
Changjie Huang
Lining Wei
RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
Cellular & Molecular Biology Letters
PAD4
GSK484
Radiosensitivity
Nasopharyngeal carcinoma
title RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
title_full RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
title_fullStr RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
title_full_unstemmed RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
title_short RETRACTED ARTICLE: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
title_sort retracted article inhibition of pad4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
topic PAD4
GSK484
Radiosensitivity
Nasopharyngeal carcinoma
url https://doi.org/10.1186/s11658-021-00251-2
work_keys_str_mv AT haochen retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT minluo retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT xiangpingwang retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT tingliang retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT chaoyuanhuang retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT changjiehuang retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells
AT liningwei retractedarticleinhibitionofpad4enhancesradiosensitivityandinhibitsaggressivephenotypesofnasopharyngealcarcinomacells